Ataxia telangiectasia and the Role of ATM

Slides:



Advertisements
Similar presentations
Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
Advertisements

P53 The Master Guardian of the Genome. p53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
ATM John Berry. What is ATM? Named “ATM” for “Ataxia-telangiectasia Mutated” gene. The mutation is recessive. Named “ATM” for “Ataxia-telangiectasia Mutated”
A signal transducer and cancer Neurofibromin, ras, and cancer - utah.
By Janet Soper and its Effects in Breast Cancer and Ovarian Cancer.
P53 The Master Guardian. R point Cell cycle control involves several checkpoints and checkpoint (molecular breaking) mechanisms.
ATM, Ataxia Telangiectasia, & Cancer
Ataxia Telangiectasia (AT) By Brandy Chapman. Characteristics of Ataxia- telangiectasia: Progressive neuronal degeneration Loss of cerebellar function.
BRCA1 The First Breast Cancer Gene Presentation By Liz Mosley.
BRCA Genes Dallas Henson.
Ataxia- telangiectasia Mutated (ATM) Brooke Register.
Cancer Cell cycle, oncogenes and tumour suppressors Jake Turner.
And Its Role in Ataxia Telangiectasia
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
BB20023/0110: Cell cycle and cancer
DNA Recombination Mechanisms AHMP Objectives List the major classes of mobile genetic elements (we went over this before) Describe the process of.
Cyclins G1 cyclin (cyclin D) S-phase cyclins (cyclins E and A) mitotic cyclins (cyclins B and A) Cyclin-dependent kinases (Cdks)kinases G1 Cdk (Cdk4) S-phase.
1 H2AX: functional roles and potential applications.
Cancer.
Bloom’s Syndrome and Bloom helicase Alexandra Otto March 16, 2004.
ATAXIA TALANGIECTASIA
1. p53 Structure, Function and Therapeutic Applications Provider: Dr.Davood Nourabadi(PhD,medical physiology) mdphysiology.persianblog.ir.
Cancer and the Cell Cycle. Outline of the lecture n What is cancer? n Review of the cell cycle and regulation of cell growth n Which types of genes when.
BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.
Cancer When cell division goes wrong……. Growing out of control, cancer cells produce malignant tumors Cancer is a general term for many diseases in.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
Breast Cancer and BRCA2. 1 million women worldwide diagnosed. 1 out of 12 women in Western Europe and the United States 30% mortality rate Highest cause.
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section D: The.
Changes in the Eukaryotic Genome By: Sergio Aguilar.
AH Biology: Unit 1 Control of the Cell Cycle. The cell cycle: summary G1G1 G2G2 S Interphase M Cytokinesis Mitosis.
FANCD2 & the Fanconi Anemia Tumor Suppressor Pathway Shayna Purcell Joo et al., 333 (6040):
Natasha Adlakha Bio445. Discovery in Breast Cancer Reverse Genetics BReast CAncer Gene Chromosome 13 Tumor suppressor gene Penetrance Familial,
Tumor Suppressor Gene Involved in Breast and Ovarian Cancers SCIENCE96/gene.cgi?BRCA1.
TSC1/Hamartin and Facial Angiofibromas Biology 169 Ann Hau.
PTEN (Phosphatase and Tensin Homolog) a.k.a. MMAC1, TEP1 Raymond Stadiem.
Janet Berrios March 19, 2009
BLOOM HELICASE (and BLOOM SYNDROME)
Paige Myers & Mahek Shah.  Cancer is a disease in which the DNA of cells becomes damaged or changed and the affected cells do not respond to apoptosis.
Tumor protein D52 represents a negative regulator of ATM protein levels Yuyan Chen, Alvin Kamili, Jayne R Hardy, Guy E Groblewski, Kum Kum Khanna, and.
Spider nevus It is also called a spider angioma or a Nevus areneus. These are common acquired vascular lesions present in over 1O% of healthy adults. They.
c-Myc A Biological Paradox
The cell cycle prokaryotic eukaryotic Control of the cell cycle loss of control- cancer What is cell differentiation and why does it happen? what is a.
New players in the BRCA1-dependent
Ch 12: Regulation of Cell Division through STP’s and cell communication
Gene Expression and Retinoblastoma “Cancer of the Eye”
GENETIC BASIS OF CANCER
Peutz-Jeghers Syndrome and LKB1/STK11
Figure: Caption: The cell cycle is controlled at several checkpoints, including one at the G2/M transition, and another in late G1 phase before.
Alterations in the Cell Cycle and Gene Mutations that Cause Cancer
FANCD2: Fanconi Anemia and Cancer
Genetic Susceptibility
BRCA1 Breast Cancer.
What makes a mutant?.
Tumor Promoting Inflammation
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
The guardian of the genome
Ataxia- Telangiectasia and ATM
B lymphocytes produce antibodies.
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
AH Biology: Unit 1 Control of the Cell Cycle
The Role of MSH2 in Hereditary Non-Polyposis Colon Cancer
Figure 1 Putative anticancer mechanisms of action of PARP inhibitors
ARF and p16: One Locus, Two Tumor Suppressors
PTEN Tumor Suppressor and Cancer
FANCF methylation contributes to chemoselectivity in ovarian cancer
Multifunctional Tumor Suppressor
Specific Tumor Suppressor Genes
ATM function in repair of double-stranded DNA breaks.
Model for the regulation of HIPK2 activity and p53 phosphorylations by the ATM pathway. Model for the regulation of HIPK2 activity and p53 phosphorylations.
Tenets of PTEN Tumor Suppression
Presentation transcript:

Ataxia telangiectasia and the Role of ATM Mary Christoph March 19, 2009 Graham, K. (2009, February 23). Brain tumour following neural (embryonic) stem cell transplant. Connecting for kids. <repairstemcell.wordpress.com/.../>

Ataxia telangiectasia Rare autosomal recessive disease Ataxia Ocular telangiectasia Immunodeficiency Radiosensitivity Cancer Caused by null mutations in the ATM protein 1 in 40-100,000 Americans and Brits Ataxia-loss of coordination, usually wheelchair-bound by 10 or 20 Telangiectasia-Prominent blood vessels in the whites of the eyes Immunodeficiency-cannot form immunglobulins correctly

Characterizing ATM 350kD serine-threonine kinase, C11 Lipid Phosphatidylinositol 3- kinase (PI(3)K) domain has kinase activity Double-strand break in DNA (DSB) causes ATM autophosphorylation Phosphorylates at least a dozen more substrates After breakage, the two molecules of the dimer phosphorylate each other to activate it

ATM has many Substrates NBS1: intra-S checkpoint, DNA repair BRCA1: activates checkpoint P53: G1S, enhanced activity CHK2: G1S checkpoint kinase, activated MDM2: ubiquitin ligase acting on p53, no longer bind and degrade p53

ATM activation leads to either DNA repair or apoptosis ATM activated at DSB sites, which starts a cascade to either repair the DNA or cause apoptosis when the damage is extensive. When ATM is mutated, however, it cannot adequately regulate its substrates, which include many proteins essential for the cell cycle, especially cell-cycle checkpoints (Shiloh, 2003). Likely redundancy because homozygous null mutants survive (cite)

Knockout Mouse Model Homozygous null ATM mutants die within 4 months Mice homozygous for nearly full-length, non- functional ATM live longer than null, but still develop tumors Heterozygous mice with null mutations have no greater risk than wt; 3aa∆ heterozygotes develop tumors (Spring et al., 2002) Homozygous null ATM mutants die from thymic tumors within 4 months after birth Mice with a homozygous 3aa∆ producing nearly full-length but non-functional ATM live longer than null, but still develop tumors Heterozygous mice with truncation mutations have no greater risk than wt; 3aa∆ heterozygotes develop tumors (Spring et al., 2002) Ozturk N. et.al. PNAS 2009;106:2841-2846

Human ATM mutations produce different effects depending on type Mutations can be either missense or null/truncations; 89% of A-T patients have truncated or null ATM proteins (Gilad et al., 1996) Missense mutations often produce less functional protein or kinase activity, NOT null, and therefore cause milder forms of A-T

ATM mutations cause cancer predisposition Heterozygous humans (0.5-1% of the population) are more likely to develop cancer (Thorstenson et al., 2003), perhaps due to LOH (Gumy-Pause et al., 2004). Mutations affecting kinase activity are implicated in tumor formation (Spring et al., 2002) Tumor types are usually leukemia or lymphoma (Gumy- Pause et al., 2004)lack of immune system maturation, DNA breakage and processing, without ATM (Perkins et al., 2002) Web Pathology, Genitourinary Tract. (2008). Hepatosplenic T-cell Lymphoma. Retrieved March 18, 2009 from Web site: webpathology.com/image.asp?case=378&n=15

Importance of the highly-conserved ATM DNA repair/apoptosis Conserved in mice, humans, Arabidopsis Mutations either truncated or missense, especially interrupted kinase activity in cancers, inadequate phosphorylation of substrates Which mutations cause cancer? Why does heterozygosity increase cancer risk? The effects in Arabidopsis thaliana of the de-activation of a gene homologous to the human ATM gene have been characterised and described. The human ATM gene is involved in the response to DNA damage, and its modification is responsible for the disease ataxia-telangiectasia, which is characterised among other things by chromosomal disorders, greater predisposition to cancers and high sensitivity to radiation. The de-activation of this gene in Arabidopsis thaliana induces a hypersensitivity to gamma radiation correlated with an inability to induce the transcription of genes involved in the detection and repair of DNA breaks, and also partial sterility due to a high occurrence of chromosome fragmentation during meiosis. These results show that this gene plays a central role in the response to DNA damage during stress and in the course of growth. They also provide important information on the mechanisms by which DNA damage is signalled in plants, about which little is known, unlike those in yeast or mammalian cells. These results were also the subject of editorial comment. Plant Cell (2003), 15 : 119-132Contact: Alain Tissier – DEVM 04.42.25.77.28 - tissier@dsvcad.cea.fr What are the redundant proteins?

References Gilad, S. et al. (1996). Predominance of null mutations in ataxia- telangiectasia. Human Molecular Genetics 5:433-439. Gumy-Pause, F. et al. (2004). ATM gene and lymphoid malignancies. Leukemia 18:238-242. Thorstenson, Y.R. et al. (2003). Contributions of ATM Mutations to Familial Breast and Ovarian Cancer. Cancer Research 63:3325- 3333. McKinnon, P.J. (2004). ATM and ataxia telangiectasia. EMBO reports 5:772-776. Shiloh, Y. (2003). ATM and related protein kinases: safeguarding genome integrity. Nature Reviews 3:155-168. Spring, K. (2002). Mice heterozygous for mutation in Atm, the gene involved in ataxia-telangiectasia, have heightened susceptibility to cancer. Nature Genetics 32:185-190.

GO HEELS!!! www.japaninc.com/mgz83/ATM-fraud